Vitura Health Ltd (ASX: VIT) Share Price and News
Price
$0.067
Movement
0.00 (0.0)
as at 13 Jun 10:24am (20 mins delayed)
52 Week Range
$0.058 - $0.135
1 Year Return
-29.47%
Vitura Health Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
$0.067
Day Change
0.00 (0.0)
52 Week Range
$0.058 - $0.135
Yesterday's Close
$0.067
Today's Open
$0.067
Days Range
$0.067 - $0.067
Volume
5,688
Avg. Volume (1 month)
307,730
Turnover
$381
as at 13 Jun 10:24am
Vitura Health Ltd (ASX: VIT)
Latest News

Cannabis Shares
How did ASX cannabis shares perform in FY22?

Cannabis Shares
Remember when ASX cannabis shares were smoking hot? Where are they now?

Cannabis Shares
How have ASX cannabis shares been performing so far in 2022?

Cannabis Shares
This little-known ASX cannabis share has quietly gained 26% in a month to trade at all-time highs

Healthcare Shares
2 ASX healthcare shares bucking the trend to hit new highs on Friday

Share Gainers
These were the best-performing ASX cannabis shares in 2021

Share Gainers
Why is the Cronos (ASX:CAU) share price soaring 45% today?

Cannabis Shares
What's the outlook for ASX Cannabis shares in 2022?

Cannabis Shares
These were the top performing ASX cannabis shares in November

Share Market News
What's going wrong for ASX cannabis shares lately?
Dividend Payment History Data provided by Morningstar.
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
04 Sep 2023 | $0.0100 | 100.00% | Final | 28 Sep 2023 |
16 Sep 2022 | $0.0100 | 100.00% | Final | 11 Oct 2022 |
VIT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
10th Jun 2025 2025-06-10T08:34:56 | Change in substantial holding | YesNo | 8:34am | 2 | 89k |
19th May 2025 2025-05-19T08:31:10 | Flora JV acquires Heyday Medical Clinic | YesNo | 8:31am | 4 | 190k |
12th May 2025 2025-05-12T08:39:59 | Q3 FY2025 business update | YesNo | 8:39am | 4 | 190k |
23rd Apr 2025 2025-04-23T09:08:31 | Change in substantial holding | YesNo | 9:08am | 3 | 275k |
22nd Apr 2025 2025-04-22T16:41:06 | Notification of cessation of securities - VIT | YesNo | 4:41pm | 4 | 13k |
10th Apr 2025 2025-04-10T16:12:51 | Response to ASX Letter about Director Trading | YesNo | 4:12pm | 5 | 431k |
7th Mar 2025 2025-03-07T17:01:18 | S&P DJI Announces March 2025 Quarterly Rebalance | YesNo | 5:01pm | 8 | 179k |
4th Mar 2025 2025-03-04T14:09:23 | Change of Director's Interest Notice | YesNo | 2:09pm | 2 | 596k |
28th Feb 2025 2025-02-28T10:10:52 | Change of Director's Interest Notice | YesNo | 10:10am | 2 | 598k |
28th Feb 2025 2025-02-28T10:01:37 | Investor webinar and presentation | YesNo | 10:01am | 26 | 4.7M |
About Vitura Health Ltd
Vitura Health Ltd. operates as a medicinal cannabis company. It engages in product and brand development, outsourced manufacturing and distribution for Australia and target export markets. The company was founded on September 27, 2018 and is headquartered in Melbourne, Australia.
VIT Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
11 Jun 2025 | $0.07 | $0.00 | 0.00% | 308,865 | $0.07 | $0.07 | $0.07 |
10 Jun 2025 | $0.07 | $0.00 | 0.00% | 342,135 | $0.07 | $0.07 | $0.07 |
06 Jun 2025 | $0.07 | $0.00 | 0.00% | 176,474 | $0.07 | $0.07 | $0.07 |
05 Jun 2025 | $0.07 | $0.00 | 0.00% | 1,011,387 | $0.07 | $0.07 | $0.07 |
04 Jun 2025 | $0.07 | $0.00 | 0.00% | 416,394 | $0.07 | $0.07 | $0.07 |
03 Jun 2025 | $0.07 | $0.00 | 0.00% | 67,556 | $0.07 | $0.07 | $0.07 |
02 Jun 2025 | $0.07 | $0.00 | 0.00% | 53,183 | $0.07 | $0.07 | $0.07 |
30 May 2025 | $0.07 | $0.00 | 0.00% | 115,500 | $0.07 | $0.07 | $0.07 |
29 May 2025 | $0.07 | $0.00 | 0.00% | 248,229 | $0.07 | $0.07 | $0.07 |
28 May 2025 | $0.07 | $0.00 | 0.00% | 355,137 | $0.07 | $0.07 | $0.07 |
27 May 2025 | $0.07 | $0.00 | 0.00% | 329,543 | $0.07 | $0.07 | $0.07 |
26 May 2025 | $0.07 | $0.00 | 0.00% | 551,223 | $0.07 | $0.07 | $0.07 |
23 May 2025 | $0.07 | $0.00 | 0.00% | 28,360 | $0.07 | $0.07 | $0.07 |
22 May 2025 | $0.07 | $0.00 | 0.00% | 24,777 | $0.07 | $0.07 | $0.07 |
21 May 2025 | $0.07 | $0.00 | 0.00% | 178,084 | $0.07 | $0.07 | $0.07 |
20 May 2025 | $0.07 | $0.00 | 0.00% | 185,133 | $0.07 | $0.07 | $0.07 |
19 May 2025 | $0.07 | $0.00 | 0.00% | 13,852 | $0.07 | $0.07 | $0.07 |
16 May 2025 | $0.07 | $0.00 | 0.00% | 1,295,778 | $0.07 | $0.07 | $0.07 |
15 May 2025 | $0.07 | $0.00 | 0.00% | 519,761 | $0.07 | $0.07 | $0.07 |
14 May 2025 | $0.07 | $0.00 | 0.00% | 10,743 | $0.07 | $0.07 | $0.07 |
13 May 2025 | $0.07 | $-0.01 | -13.61% | 497,816 | $0.07 | $0.08 | $0.07 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
04 Mar 2025 | Gerard Fogarty | Buy | 332,000 | $24,900 |
On-market trade.
|
27 Feb 2025 | Rebecca Wilson | Buy | 228,000 | $19,835 |
On-market trade.
|
26 Feb 2025 | Robert Iervasi | Buy | 344,550 | $29,631 |
On-market trade.
|
04 Sep 2024 | Robert Iervasi | Buy | 179,200 | $15,076 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Shane Francis Tanner | Non-Executive Director | Oct 2018 |
Mr Tanner is an Executive and Director with a record over many years of operating in multiple industries and markets. Shane was formerly CFO of an ASX Top 25 company (Mayne Nickless Limited (ASX: MAY)), as well as the inaugural CEO of Symbion Health (formerly known as Mayne Nickless Diagnostic Services). He also played a role in the float of Optus Communications. Over the past 20 years, Shane has been involved with multiple successful IPOs (including Vitura in November 2019) and many large-scale mergers and acquisitions. He has served as either the Chair or Non-Executive Director on more than ten public company boards and many other private companies.
|
Ms Rebecca Jayne Wilson | Non-Executive Director | Nov 2024 |
Ms Wilson is a company director with private, ASX-listed and not for-profit organisations. She is currently the Non-Executive Chair of global healthcare technology company, Alcidion Limited (ASX: ALC), and Ai-enabled technology platform LBT Innovations (ASX: LBT), and a Non-Executive Director of ASX listed enterprise technology company Hansen Technologies (ASX: HSN), and not-for-profit Tomisich Foundation. In an executive career spanning 25 years, she held global leadership roles in marketing communication, brand positioning, investor relations, capital management, and corporate affairs. She has expertise in ESG, complex stakeholder communication, brand awareness, issues, crisis and risk management, transactions, and investor relations. She has experience leading companies in commercial activation phases working with CEOs as both an advisor and Non-Executive Director. Shes worked as a NED since 2017, including Committee representation on Remuneration and Nominations (including as Chair), M&A, ESG, and Audit and Risk.
|
Mr Robert Iervasi | Non-Executive ChairmanNon-Executive Director | Feb 2024 |
Mr Iervasi as the former Group CEO and Director of Asahi Beverages, Robert led a diversified consumer products / FMCG business with more than $5 billion in annual revenue and over 5,000 employees, including a manufacturing footprint. Prior to this, he served as the Group COO and CFO and General Counsel of Asahi for over eight years, managing Finance, Shared Business Services, Legal, Risk Strategy and Information Technology, as well Sales, Marketing, Supply Chain and Science and Innovation. Robert has successfully driven profitability and growth across multiple categories, brands and channels. In 2020, he identified and executed the acquisition by Asahi of Carlton & United Breweries. Robert brings experience and expertise in governance, finance, law, and innovation to Vitura.
|
Mr Gerard Paul Fogarty | Non-Executive Director | Nov 2024 |
Mr Fogarty is a non-executive director and CEO.His board and executive roles have a variety of sectors, including national security, industrial relations regulation, work health and safety regulation, compensation and rehabilitation regulation, medical research, human performance research and health insurance. His background spans entities, including statutory authorities, joint ventures, industry bodies, not-for-profits and advisory boards. He was most recently a CEO of a private health insurer.
|
Mr Daniel Francis Birch | Non-Executive Director | Nov 2024 |
Mr Birch has 20 years experience advising clients across a range of industries.
|
Mr Thomas Godfrey Howitt | Chief Financial OfficerCompany SecretaryInterim CEO | Aug 2020 |
-
|
Mr Geoff Cockerill | Chief Executive Officer | Nov 2024 |
-
|
Geoff Cockerill | Chief Executive Officer |
-
|
|
Thomas Godfrey Howitt | Chief Financial OfficerCompany SecretaryInterim CEO |
-
|
|
Nicola M. Swarbrick | Chief Operating Officer |
-
|
|
Ryan Tattle | Chief Revenue Officer |
-
|
|
Stefan Schmidt | Chief Technology Officer |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Elizabeth Sarah Jansen <Stanford Investment Trust> | 118,757,765 | 20.62% |
Guy Rothwell Headley | 95,548,772 | 16.59% |
Cronos Global Holdings Inc. | 55,176,065 | 9.58% |
Matua Hasyo Charlie Jansen <Whanau Family Trust> | 44,117,428 | 7.66% |
NewSouthern Investment Holdings 1 Pty Ltd <NewSouthern Investment Trust 1> | 21,000,000 | 3.65% |
NewSouthern Investment Holdings A Pty Ltd | 18,441,007 | 3.20% |
Citicorp Nominees Pty Limited | 13,225,910 | 2.31% |
HSBC Custody Nominees (Australia) Limited | 11,284,879 | 1.96% |
Ashanna Pty Ltd | 10,766,897 | 1.87% |
Melbourne Securities Corporation Limited <BV1 Fund A/C> | 9,000,000 | 1.56% |
Stone Group Pty Ltd <Stone Children A/C> | 6,377,765 | 1.11% |
UBS Nominees Pty Ltd | 5,833,174 | 1.01% |
EJ Watson (Medical) Pty Ltd <The EJ Watson Med S/F A/C> | 5,000,000 | 0.87% |
Jessimine Jansen | 4,253,379 | 0.74% |
Hektares SG Holdings Pte Ltd | 4,050,940 | 0.70% |
Daniel Francis Birch <BES A/C> | 3,766,498 | 0.65% |
Craig Graeme Chapman <Nampac Discretionary A/C> | 3,500,000 | 0.61% |
Ryan Tattle | 3,451,189 | 0.60% |
Robert Charles Hussey | 3,000,000 | 0.52% |
William David Copland and Susan Mary Copland David Copland Super fund A/C> | 2,484,000 | 0.43% |